Citations (7)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Ruliang Ding, Weiwen Hong, Liang Huang, Jinfan Shao, Wenfeng Yu & Xijuan Xu. (2022) Examination of the effects of microRNA-145-5p and phosphoserine aminotransferase 1 in colon cancer. Bioengineered 13:5, pages 12794-12806.
Read now
Read now
Ying Zhou, Wei Cai & Hailin Lu. (2022) Overexpression of microRNA-145 enhanced docetaxel sensitivity in breast cancer cells via inactivation of protein kinase B gamma-mediated phosphoinositide 3-kinase -protein kinase B pathway. Bioengineered 13:4, pages 11310-11320.
Read now
Read now
Man Zhang, Jinhua Zheng, Junying Guo, Qiujin Zhang, Juan Du, Xiangfeng Zhao, Zhihua Wang & Qinyuan Liao. (2022) SIA-IgG confers poor prognosis and represents a novel therapeutic target in breast cancer. Bioengineered 13:4, pages 10072-10087.
Read now
Read now
Ding Li, Ding Wang, Haofeng Liu & Xiaohui Jiang. (2022) LEM domain containing 1 (LEMD1) transcriptionally activated by SRY-related high-mobility-group box 4 (SOX4) accelerates the progression of colon cancer by upregulating phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway. Bioengineered 13:4, pages 8087-8100.
Read now
Read now
Articles from other publishers (3)
Abdollah Jafarzadeh, Seyedvahid Seyedmoalemi, Amirreza Dashti, Maryam Nemati, Sara Jafarzadeh, Najmeh Aminizadeh, Massoud Vosough, Ali Rajabi, Ali Afrasiabi & Hamed Mirzaei. (2022) Interplays between non-coding RNAs and chemokines in digestive system cancers. Biomedicine & Pharmacotherapy 152, pages 113237.
Crossref
Crossref
Tânia R. Dias, Francisca Dias, Ana Luísa Teixeira, Hugo Sousa, Júlio Oliveira & Rui Medeiros. (2022) MicroRNAs as Potential Tools for Predicting Cancer Patients’ Susceptibility to SARS-CoV-2 Infection and Vaccination Response. Cells 11:15, pages 2279.
Crossref
Crossref
Linpei Wang, Xiaoqiu Ma, Youqi Chen, Jiahui Zhang, Jiawei Zhang, Wei Wang & Shaojian Chen. (2022) MiR-145-5p Suppresses Hepatocellular Carcinoma Progression by Targeting ABHD17C. Oncologie 24:4, pages 897-912.
Crossref
Crossref